Orexa, Announces

Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Orexa B.V. Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom Oregon

en | boerse | 67995868 |